MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Charles River Laboratories Company Profile (NYSE:CRL)

Consensus Ratings for Charles River Laboratories (NYSE:CRL) (?)
Ratings Breakdown: 1 Sell Rating(s), 4 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $81.36 (19.37% upside)

Current Analysts' Coverage Summary for Charles River Laboratories (NYSE:CRL)
Show:
DateFirmActionRatingPrice TargetActions
8/16/2015JefferiesReiterated RatingBuy$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2016Robert W. BairdBoost Price TargetOutperform$86.00 -> $92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2016Jefferies GroupReiterated RatingBuy$88.00 -> $96.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Wells FargoUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Deutsche BankBoost Price TargetHold$79.00 -> $81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2015Credit SuisseInitiated CoverageNeutral$84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Citigroup Inc.Reiterated RatingHold$75.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015Morgan StanleyReiterated RatingEqual Weight$65.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015Bank of AmericaUpgradeNeutral -> Buy$76.00 -> $83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015BarclaysDowngradeEqual Weight -> Underweight$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Edward JonesUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015SunTrustUpgradeNeutral -> Buy$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Cantor FitzgeraldReiterated RatingBuy$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2014Raymond JamesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014KeyBancInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2014Ned Davis ResearchUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/10/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha